Plasma Interleukin-6 Levels in Patients with Cirrhosis: Relationship to Endotoxemia, Tumor Necrosis Factor-α, and Hyperdynamic Circulation

Scandinavian Journal of Gastroenterology

Volumn 31, Issue 5, 1996, Pages 500-505

  Lee, F Y ^a,b   Lu, R H ^a   Tsai, Y T ^a   Lin, H C ^a   Hou, M C ^a   Li, C P ^a   Liao, T M ^a   Lin, L F ^a   Wang, S S ^a   Lee, S D ^a  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Cirrhosis; Hyperdynamic circulation; Interleukin 6; Portal hypertension; Tumor necrosis factor

Indexed keywords

ENDOTOXIN; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; CATHETERIZATION; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEMODYNAMICS; HUMAN; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; PORTAL HYPERTENSION; PRIORITY JOURNAL; SWAN GANZ CATHETER;

BLOOD CIRCULATION; CASE-CONTROL STUDIES; CATHETERIZATION, SWAN-GANZ; ENDOTOXINS; FEMALE; HEMODYNAMIC PROCESSES; HUMANS; INTERLEUKIN-6; LIVER; LIVER CIRRHOSIS; MALE; MIDDLE AGED; TUMOR NECROSIS FACTOR-ALPHA; VASODILATION;

EID: 0029883170     PISSN: 00365521     EISSN: None     Source Type: Journal    
DOI: 10.3109/00365529609006772     Document Type: Article

References (41)

1. Genecin P, Groszmann RJ. Portal hypertension. In: Schiff E, Schiff L, editors. Diseases of the liver. 7th ed. Philadelphia: Lippincott, 1993:935-73.
2. Colombato LA, Albillos A, Groszmann RJ. Temporal relationship of peripheral vasodilatation, plasma volume expansion and the hyperdynamic circulatory state in portal hypertensive rats. Hepatology 1991;15:323-8.
3. Albillos A, Colombato LA, Groszmann RJ. Vasodilatation and sodium retention in prehepatic portal hypertension. Gastroenterology 1992;102:931-5.
4. Pizcueta MP, Piqué JM, Bosch J, Whittle BJR, Moncada S. Effects of inhibiting nitric oxide biosynthesis on the systemic and splanchnic circulation of rats with portal hypertension. Br J Pharmacol 1992;105:184-90.
5. ω-Nitro-L-arginine administration corrects peripheral vasodilatation and systemic capillary hypotension and ameliorates plasma volume expansion and sodium retention in portal hypertensive rats. Hepatology 1993;17:84-90.
6. Lumsden AB, Henderson JM, Kutner MH. Endotoxin levels measured by a chromogenic assay in portal, hepatic and peripheral venous blood in patients with cirrhosis. Hepatology 1988;8:232-6.
7. Fukui H, Brauner B, Bode JC, Bode C. Plasma endotoxin concentrations in patients with alcoholic and non-alcoholic liver disease: reevaluation with an improved chromogenic assay. J Hepatol 1991;12:162-9.
8. Bigatello LM, Broitman SA, Fattori L, Di Paoli M, Pontello M, Bevilacqua G, et al. Endotoxemia, encephalopathy, and mortality in cirrhotic patients. Am J Gastroenterol 1987;82: 11-5.
9. Lin RS, Lee FY, Lee SD, Tsai YT, Lin HC, Lu RH, et al. Endotoxemia in patients with chronic liver diseases: relationship to severity of liver diseases, presence of esophageal varices, and hyperdynamic circulation. J Hepatol 1995;22:165-72.
10. Julou-Schaeffer G, Gray GA, Fleming I, Schott C, Parratt JR, Stoclet JC. Loss of vascular responsiveness induced by endotoxin involves L-arginine pathway. Am J Physiol 1990; 259:H1038-43.
11. Rees DD, Cellek S, Palmer RMJ, Moncada S. Dexamethasone prevents the induction by endotoxin of a nitric oxide synthase and the associated effects on vascular tone: an insight into endotoxin shock. Biochem Biophys Res Commun 1990;173: 541-7.
12. Suffredini AF, Fromm RE, Parker MM, Brenner M, Kovacs JA, Wesley RA, et al. The cardiovascular response of normal humans to the administration of endotoxin. N Engl J Med 1989;321:280-7.
13. Parker MM, Parrillo JE. Septic shock-hemodynamics and pathogenesis. JAMA 1983;250:3324-7.
14. Vallance P, Moncada S. Hyperdynamic circulation in cirrhosis: a role for nitric oxide? Lancet 1991;337:776-8.
15. Fong Y, Marano MA, Moldawer LL, Wei H, Calvano SE, Kenney JS, et al. The acute splanchnic and peripheral tissue metabolic response to endotoxin in humans. J Clin Invest 1990;85:1896-904.
16. Kuhns DB, Alvord WG, Gallin JI. Increased circulating cytokines, cytokine antagonists, and E-selectin after intravenous administration of endotoxin in humans. J Infect Dis 1995;171: 145-52.
17. Devière J, Content J, Denys C, Vandenbussche P, Schanden L, Wybran J, et al. Excessive bacterial lipopolysaccharide-induced production of monokines in cirrhosis. Hepatology 1990;11: 628-34.
18. Khoruts A, Stahnke L, McClain CJ, Logan G, Allen JI. Circulating tumor necrosis factor, interleukin-1 and interleukin-6 concentrations in chronic alcoholic patients. Hepatology 1991;13:267-76.
19. Tilg H, Wilmer A, Vogel W, Herold M, Nölchen B, Judmaier G, et al. Serum levels of cytokines in chronic liver diseases. Gastroenterology 1992;103:264-74.
20. G-methyl-L-arginine inhibits tumor necrosis factor-induced hypotension: implications for the involvement of nitric oxide. Proc Natl Acad Sci USA 1990;87:3629-32.
21. Busse R, Mülsch A. Induction of nitric oxide synthase by cytokines in vascular smooth muscle cells. Febs Letters 1990;275:87-90.
22. Fong Y, Tracey KJ, Moldawer LL, Hesse DG, Manogue KB, Kenney JS, et al. Antibodies to cachetin/tumor necrosis factor reduce interleukin 1 beta and interleukin 6 appearance during lethal bacteremia. J Exp Med 1989;170:1627-33.
23. Lopez-Talavera JC, Merrill WW, Groszmann RJ. Tumor necrosis factor α: a major contributor to the hyperdynamic circulation in prehepatic portal-hypertensive rats. Gastroenterology 1995;108:761-7.
24. Ohkawa F, Ikeda U, Kawasaki K, Kusano E, Igarashi M, Shimada K. Inhibitory effect of interleukin-6 on vascular smooth muscle contraction. Am J Physiol 1994;266:H898-902.
25. Di Lelio A, Cestari C, Lomazzi A, Beretta L. Cirrhosis: diagnosis with sonographic study of the liver surface. Radiology 1989;172:389-92.
26. Pugh RNH, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the esophagus for bleeding esophageal varices. Br J Surg 1973;60:646-9.
27. Tsai YT, Lee FY, Lin HC, Chang TT, Lay CS, Wang SS, et al. Lack of effects of isosorbide-5-mononitrate on hepatic hemodynamics in HBsAg positive cirrhosis. Hepatology 1989;10: 283-7.
28. Munford RS, Hall CL. Uptake and deacylation of bacterial lipopolysaccharides by macrophages from normal and endotoxin-hyporesponsive mice. Infect Immun 1985;48:464-73.
29. Fukuda I, Tanamoto K, Kanegasaki S, Yajima Y, Goto Y. Deacylation of bacterial lipopolysaccharide in rat hepatocytes in vitro. Br J Exp Path 1989;70:267-74.
30. Curtiss SI, Eickmeyer D, Faire B, Mor E, Emre S, Sheiner PA, et al. Cytokine levels correlate with disease severity in patients with end-stage liver disease [abstract]. Hepatology 1994;20: 191A.
31. Guarner C, Soriano G, Tomas A, Bulbena O, Novella MT, Balanzo J, et al. Increased serum nitrite and nitrate levels in patients with cirrhosis: relationship to endotoxemia. Hepatology 1993;18:1139-43.
32. Andus T, Bauer J, Gerok W. Effects of cytokines on the liver. Hepatology 1991;13:364-75.
33. Metha R, Gottstein J, Zeller WP, Lichtenberg R, Blei AT. Endotoxin and the hyperdynamic circulation of portal veinligated rats. Hepatology 1990;12:1152-6.
34. Lee FY, Wang SS, Yang MCM, Tsai YT, Wu SL, Lu RH, et al. Role of endotoxemia in hyperdynamic circulation in rats with extrahepatic or intrahepatic portal hypertension. J Gastroenterol Hepatol 1995. In press.
35. Garcia-Tsao G, Albillos A, Barden GE, West B. Bacterial translocation in acute and chronic portal hypertension. Hepatology 1993;17:1081-5.
36. Sorell TW, Eamonn M, Quigley M, Gongliang J, Johnson TJ, Rikkers LF. Bacterial translocation in the portal-hypertensive rats: studies in basal conditions and on exposure to hemorrhagic shock. Gastroenterology 1993;104:1722-6.
37. Garcia-Tsao G, Lee FY, Barden GE, Cartun R, West AB. Bacterial translocation to mesenteric lymph nodes is increased in cirrhostic rats with ascites. Gastroenterology 1995;108: 1835-41.
38. Tartaglia LA, Rothe M, Hu YF, Goeddel DV. Tumor necrosis factor's cytotoxic activity is signaled by the p55 TNF receptor. Cell 1993;73:213-6.
39. Henriksen JH. Cirrhosis: ascites and hepatorenal syndrome. Recent advances in pathogenesis. J Hepatol 1995;23 Suppl 1:25-30.
40. Sheron N, Lau JYN, Hofmann J, Alexander GJM, William R. Dose dependent increase in plasma interleukin-6 after recombinant tumor necrosis infusion in humans. Clin Exp Immunol 1990;82:427-8.
41. Finkel MS, Oddis CV, Jacob JD, Watkins SC, Hattler BG, Simmons RL. Negative inotropic effects of cytokines on the heart mediated by nitric oxide. Science 1992;257:387-9.